Clinical trial

Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit

NCT03168529

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-07-01

PhasePHASE4

Study timeline

Study start (actual)2018-07-01Date precision: day

Registry last updated2026-09-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

IvabradineDRUG · verified · RxNorm: ivabradine

PlaceboDRUG

Sponsors & collaborators

Phillip Levylead sponsor

Amgencollaborator

iRhythm Technologies, Inc.collaborator

Mapped research locations

DetroitMichigan, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03168529 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.